Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review
- PMID: 31410661
- PMCID: PMC6692448
- DOI: 10.1007/s11920-019-1072-6
Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review
Abstract
Purpose of review: Poor treatment response is a hallmark of major depressive disorder. To tackle this problem, recent neuroimaging studies have sought to characterize antidepressant response in terms of pretreatment differences in intrinsic functional brain networks. Our aim is to review recent studies that predict antidepressant response using intrinsic network connectivity. We discuss current methodological limitations and directions for future antidepressant biomarker studies.
Recent findings: Functional connectivity stemming from the subgenual and rostral anterior cingulate has shown particular consistency in predicting antidepressant response. Differences in this connectivity may prove fruitful in differentiating treatment responders to many antidepressant interventions. Future biomarker studies should integrate biological MDD subtypes to address the disorder's inherent clinical heterogeneity. These clinical and scientific advancements have the potential to address this population marked by limited treatment response. Methodological considerations, including patient selection, response criteria, and model overfitting, will require future investigation to ensure that biomarkers generalize for prospective prediction of treatment response.
Keywords: Biomarker; Brain networks; Major depressive disorder; Network connectivity; Predictor; Treatment response.
Conflict of interest statement
Katharine Dunlop and Aleksandr Talishinsky each declare that they have no conflict of interest.
Conor Liston is listed as an inventor for a Cornell University pending patent application, “Neuroimaging Biomarkers for Diagnosing Depression Subtypes.”
Figures

References
-
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917. - PubMed
-
- Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40. - PubMed
-
- Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R, Haro JM. Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder? J Affect Disord. 2013;149:182–188. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials